NDC 58151-079 – Cardura XL
Doxazosin Mesylate 8 mg/1 · Tablet, Film Coated, Extended Release · Oral
Product NDC58151-079
Product details
- Brand name
- Cardura XL
- Generic name
- Doxazosin mesylate
- Labeler
- Viatris Specialty LLC
- Dosage form
- Tablet, Film Coated, Extended Release
- Route
- Oral
- Marketing category
- NDA · NDA021269
- Marketed since
- January 4, 2024
- Listing expires
- December 31, 2026
- Pharmacologic class
- alpha-Adrenergic Blocker
Active ingredients
- Doxazosin Mesylate 8 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 58151-079-93 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (58151-079-93) | Jan 4, 2024 |
Recalls mentioning this NDC
- D-0204-2025 Jan 22, 2025 · Class II
Failed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing. - D-0203-2025 Jan 22, 2025 · Class II
Failed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing.
Other Cardura products
- 0049-2512 Doxazosin Mesylate 2 mg/1 · Tablet · ROERIG
- 0049-2614 Doxazosin Mesylate 4 mg/1 · Tablet · ROERIG
- 0049-2716 Doxazosin Mesylate 8 mg/1 · Tablet · ROERIG
- 58151-074 Doxazosin Mesylate 1 mg/1 · Tablet · Viatris Specialty LLC
- 58151-075 Doxazosin Mesylate 2 mg/1 · Tablet · Viatris Specialty LLC
- 58151-076 Doxazosin Mesylate 4 mg/1 · Tablet · Viatris Specialty LLC
- 58151-077 Doxazosin Mesylate 8 mg/1 · Tablet · Viatris Specialty LLC
- 58151-078 Doxazosin Mesylate 4 mg/1 · Tablet, Film Coated, Extended Release · Viatris Specialty LLC